Admission plasma glucose: Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients

Diabetes Care

Volumn 22, Issue 11, 1999, Pages 1827-1831

  Norhammar, Anna M ^a   Rydén, Lars ^a   Malmberg, Klas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; DIAGNOSTIC TESTS, ROUTINE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032757986     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.11.1827     Document Type: Article

References (28)

1. O'Sullivan J, Conroy R, Robinson K, Hickey N, Mulcahy R: In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 14:758-760, 1991
2. Fava S, Aquilina O, Azzopardi J, Muscat H, Fenech F: The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabet Med 13:80-83, 1996
3. Oswald G, Smith C, Betteridge J, Yudkin J: Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J 293: 917-922, 1986
4. Mak K, Mah P, Tey B, Sin F, Chia G: Fasting blood sugar level: a determinant for in hospital outcome in patients with first myocardial infarction and without glucose intolerance. Ann Acad Med Singapore 22: 291-295, 1993
5. Bellodi G, Manicardi V, Malvasi V, Veneri L, Bernini G, Bossini P, Distefano S, Magnanini G, Muratori L, Rossi G, Zuarini A: Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 64:885-888, 1989
6. Weir CJ, Murray GD, Dyker AG, Lees KR: Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 314:1303-1306, 1997
7. Pyörälä K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P: Glucose tolerance and coronary heart disease: Helsinki policemen study. J Chronic Dis 32:729-745, 1979
8. Fuller JH, Shipley MJ, Rose G, Jarre RJ, Keen H: Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet i: 1373-1376, 1980
9. Gerstein H, Yusuf S: Dysglycaemia and risk of cardiovascular disease. Lancet 347: 949-950, 1996
10. Joint International Society and Federation of Cardiology/World Health Organization: Nomenclature and criteria for diagnosis of ischemic heart disease: repon of the task force on standardization of clinical nomenclature. Circulation 59:607-609, 1979
11. Malmberg K, Norhammar A, Rydén L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626-2632, 1999
12. Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenström A, Wedel H: Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res 34:248-253, 1997
13. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
14. Uusitupa M, Niskanen L, Siitonen O, Voutilainen E, Pyörälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
15. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
16. Andersson D, Svärdsudd K: Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 18:1534-1543, 1995
17. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
18. UK Prospective Diabetes Study (UKPDS) Group: Intense blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
19. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C: Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Md 322: 1769-1774, 1990
20. Schneider DJ, Nordt TK, Sobel BE: Attenuated fibrinolysis and accelerated atherogenesis in type 2 diabetic patients. Diabetes 42: 1-7, 1993
21. Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor I levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 34:457-462, 1991
22. Williams SB, Goldfine AB, Timimi FT, Ting HH, Roddy M-A, Simonson DC, Creager MA: Acute hyperglycemia attenuates endo-thelium-dependent vasodilation in humans in vivo. Circulation 97:1695-1701, 1998
23. Laakso M, Letho S, Penttilä I, Pyöräla K: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430, 1993
24. Rodrigues B, McNeill JH: The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovosc Res 26:913-922, 1992
25. Lindström T, Arnqvist H, Olsson A: Effect of different insulin regimens on plasma lipoproteins and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 81: 137-144, 1990
26. Romano G, Patti L, Innelli F, Di Marino L, Annuzzi G, Iavicoli M, Coronel GA, Riccardi G, Rivellese AA: Insulin and sulfonylurea therapy in NIDDM patients: are the effects on lipoprotein metabolism different even with similar blood glucose control? Diabetes 46:1601-1606, 1997
27. Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS: Insulin therapy in type 2 diabetic subjects supresses plasminogen activator inhibitor (PAI-1) activity and proinsulinlike molecules independently of glycaemic control. Diabet Med 10:27-32, 1993
28. Yokoyama I, Momomura S-I, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, Omata M: Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 30:1472-1477, 1997